5th Floor, Brigade Towers,
Financial District, Gachibowli,
Hyderabad - 500032,
The Spain Over-the-Counter (OTC) Drugs Market is segmented by Product and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacy, and Other Distribution Channels).
The Spanish over-the-counter (OTC) drugs market is expected to register a CAGR of around 3.5% over the forecast period. Factors that are propelling the growth of this market include product innovation, growing distribution channels, an inclination of the pharmaceutical companies from Rx to OTC drugs, and increasing self-medication among the general population.
Over-the-counter (OTC) medications do not need a doctor’s prescription. This convenience for consumers enables the direct purchase of medicine.
|Cough, Cold, and Flu Products|
|Vitamins, Mineral, and Supplements (VMS)|
|Other Product Types|
|By Distribution Channel|
|Other Distribution Channels|
Report scope can be customized per your requirements. Click here.
The magnitude of savings due to the advent of over-the-counter (OTC) drugs in the cough/cold/flu category is driven by a rise in the number of individuals affected by these conditions. The growing prevalence of these common diseases (i.e., cough, cold, and flu) has led the patients to use OTC drugs, as these drugs are readily available and can be bought without a doctor’s prescription. This saves both time and cost required to visit a physician/hospital. Consumers depend on OTC for cough and cold medicines as the first response is to seek quick relief from symptoms. Owing to their easy procurement and increasing market demand, the sale of OTC drugs for cough, cold, and flu is increasing in Spain.
Quick-relief tablets, such as throat lozenges, provide quick relief from throat tickles and contribute to the market as well. Aspirin is widely used to provide quick relief from headaches. The improved quality and efficacy of cough, cold, and flu OTC products are strongly driving the market.
To understand key trends, Download Sample Report
The Spanish over-the-counter (OTC) drugs market is highly competitive. There are some major players that are holding the major share in the market, along with some of the smaller companies holding a substantial share. However, with technological advancements and product innovation, mid-size to smaller companies are increasing their market presence by introducing new products with fewer prices.
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Inclination of Pharmaceutical Companies to Switch From Rx to OTC
4.2.2 Increasing Self Medication among General Population
4.2.3 High Penetration in Emerging Markets
4.3 Market Restraints
4.3.1 Incorrect Self Diagnosis
4.3.2 Probability of Substance Abuse
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
5.1 By Product
5.1.1 Cough, Cold, and Flu Products
5.1.3 Dermatology Products
5.1.4 Gastrointestinal Products
5.1.5 Vitamins, Mineral, and Supplements (VMS)
5.1.6 Weight-loss/Dietary Products
5.1.7 Ophthalmic Products
5.1.8 Sleeping Aids
5.1.9 Other Product Types
5.2 By Distribution Channel
5.2.1 Retail Pharmacies
5.2.2 Online Pharmacy
5.2.3 Other Distribution Channels
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.2 Sanofi SA
6.1.3 Pfizer Inc.
6.1.4 GlaxoSmithKline PLC
6.1.5 Reckitt Benckiser Group PLC
6.1.6 Takeda Pharamaceutical Company Ltd
6.1.7 Johnson and Johnson
6.1.8 Novartis AG
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
**Competitive Landscape Covers- Business Overview, Financials, Products and Strategies, and Recent Developments